DCAT Value Chain Insights Podcast – Older Episodes
Podcast Archive
Listen to specially selected articles from our website that feature in-depth analysis on the issues impacting the business of pharmaceutical development and manufacturing.
API Watch: Small Molecules
September 4, 2020
In this podcast, we feature an article that looks at the small molecules approved as new molecular entities thus far in 2020 and which have blockbuster potential.
This podcast is sponsored by: Dr. Reddy’s Laboratories
The Top 10 Deals for Pharma Innovation
August 24, 2020
In this podcast, we feature the top 10 deals thus far in 2020 and which pharma/biopharma companies are rising to the top.
This podcast is sponsored by: LabVantage Solutions
Novel Excipients: Gaining Traction in the Industry
August 10, 2020
In this podcast, we feature an article that outlines the FDA’s proposed pilot program for the evaluation of novel excipients and summarizes industry feedback on the review program.
This podcast is sponsored by: LabVantage Solutions
Re-configuring Global Pharma Supply Chains
July 10, 2020
In this podcast, we feature an article that looks at the policy debate to repatriate and increase domestic drug manufacturing in the US in light of the COVID-19 pandemic and pharmaceutical supply-chain vulnerabilities.
2020 Vision: DIgital Pharma – Beyond the Pill
June 29, 2020
In this podcast we feature an article that explores the future of digital medicines.
A Top 10 Emerging Pharma Watch List
June 22, 2020
In this podcast we feature DCAT Value Chain Insights’ Top 10 Emerging Pharma Watch List based on recent high-value partnering deals.
CDMOs Step Up to the COVID Challenge but Must Prepare for Uncertain Future
June 11, 2020
In this podcast, we feature an article that looks at the near-term and long-term impact of the COVID-19 pandemic as biopharma companies re-access drug-development projects.
Tracking Expansion in High-Potency Manufacturing
June 4, 2020
In this podcast, we round up key recent expansions in high-potency manufacturing by CDMOs and CMOs.
DCAT Benchmarking Study Provides Insight into Supply-Chain Challenges
May 28, 2020
In this podcast, we feature an article about a recent DCAT Benchmarking study, conducted prior to COVID-19, that provides insights on whether biopharma companies and their suppliers believe the deteriorating trade environment is a major threat, and what they are doing to confront the real and potential risks to their supply chains.
Pharma Company on the Move: The New AbbVie
May 22, 2020
In this podcast, we feature an article that examines the new AbbVie, including the key products and expanded manufacturing networking, resulting from its recent acquisition of Allergan.
Re-inventing US Pharma Mfg and Supply Chains
May 15, 2020
In this podcast, we feature an article about the Association for Accessible Medicines’ blueprint to facilitate a repatriation of pharma manufacturing to the US.
Supplying Potential COVID-19 Treatments & Vaccines
May 13, 2020
In this podcast, we outline the manufacturing strategies and alliances that are in play to develop and supply treatments and vaccines against COVID-19.
This podcast is sponsored by: CordenPharma
Drug Development in the Wake of COVID-19
May 1, 2020
In this podcast, we feature an article that examines the effect of COVID-19 on drug development, clinical trials, regulatory review, and new drug approvals.
This podcast is sponsored by: CordenPharma
A Top 10 Watch List: Biologics and Biomanufacturing
April 27, 2020
In this podcast we feature DCAT Value Chain Insights’ Top 10 Watch List for Biologics and Biomanufacturing.
This podcast is sponsored by: CordenPharma
Facilitating Sourcing in the Wake of COVID-19
April 17, 2020
In this podcast, we feature an article that outlines the guidance issued by EU authorities to provide flexibility in sourcing for crucial medicines for the treatment of COVID-19.
This podcast is sponsored by: CordenPharma
COVID-19’s Impact on Global Pharma Supply Chains
April 06, 2020
In this podcast, we feature an article that reports on the concerns raised by industry groups, including reduced availability of international air transportation and increasing costs for shipping medicines into the US.
This podcast is sponsored by: CordenPharma
Indian Government Looks to Increase API Manufacturing
March 27, 2020
In this podcast, we feature an article that looks at the Indian government’s $1.3-billion multi-year plan to increase domestic production of key starting materials and active pharmaceutical ingredients and its potential impact on global supply chains.
This podcast is sponsored by: CordenPharma
Drug Supply Chains and US-Based Manufacturing
March 23, 2020
What does the global nature of the pharmaceutical supply chain mean for US policy? In this podcast, we feature an article that looks at proposals from members of Congress and the federal government to incentivize domestic drug manufacturing in the US.
This podcast is sponsored by: CordenPharma
Blockbuster Watch for 2020: New Market Entrants
March 2, 2020
What are the new blockbuster medicines to watch? In this podcast we feature an article that examines the eleven medicines projected to enter the market in 2020 and achieve blockbuster status by 2024, according to a recent analysis by Clarivate Analytics’ Cortellis Forecast Team.
This podcast is sponsored by: CordenPharma
Orphan Drugs: Bearing Revenue Gains or Not?
February 25, 2020
Over the past several years, orphan drugs have accounted for more than 40% of new drug approvals by the FDA. In this podcast, we showcase an article that explores whether they are producing the revenue gains pharma companies are seeking or if they are too niche?
This podcast is sponsored by: CordenPharma
Emerging Biopharma Companies: Tracking Their Contribution to Innovation
February 14, 2020
To what extent do emerging pharma companies contribute to the pharmaceutical industry’s pipeline and new product growth? In this podcast, we showcase an article examining a recent report by IQVIA that analyzes emerging bio pharma companies’ contribution to innovation.
This podcast is sponsored by: CordenPharma
20-20 Insights and Outlook for the CDMO Market
January 15, 2020
The conditions are favorable for another strong year of performance for CDMOs. In this podcast, we showcase an article written by Jim Miller, Consultant and Content Advisor at DCAT, that examines industry fundamentals and an outlook for pharma outsourcing in 2020.
This podcast is sponsored by: CordenPharma